Specifically, the p38MAPK pathway was found to mediate the proapoptotic activity of GnRH analogs in BPH-1 cells while the ERK kinase was shown to be activated by GnRH agonists in immortalized human prostate cells engineered to overexpress the GnRH-R. This evidence concerns the gene GNRH1 and benign prostatic hyperplasia.